• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二型糖尿病的血栓形成和心血管风险;血小板活性亢进的作用。

Thrombotic and cardiovascular risks in type two diabetes; Role of platelet hyperactivity.

机构信息

Menzies Health Institute Queensland, Griffith University, Gold Coast Campus, Parkland Drive, Southport, Queensland, 4222, Australia; National Centre of Hematology, Almustansiriah University, Alyarmook, Baghdad, Iraq.

Menzies Health Institute Queensland, Griffith University, Gold Coast Campus, Parkland Drive, Southport, Queensland, 4222, Australia.

出版信息

Biomed Pharmacother. 2017 Oct;94:679-686. doi: 10.1016/j.biopha.2017.07.121. Epub 2017 Aug 16.

DOI:10.1016/j.biopha.2017.07.121
PMID:28787703
Abstract

One of the most commonly identified chronic illnesses in many countries is type 2 diabetes mellitus (T2DM). T2DM denotes an independent risk factor for cardiovascular disease (CVD). Heart disease is one of the causes of mortality in patients with diabetes, mainly due to the macrovascular complications. One of these macrovascular complications in diabetes is atherosclerosis, which involves a complicated pathophysiological process. Besides hyperglycemia, oxidative stress plays a significant role in the pathogenesis of diabetes and its associated risk of CVD. There are many other factors including molecular, metabolic, lipid, fibrinolytic, and platelet function disorders precipitate to thrombotic and CVD risks in T2DM. Also, Platelets have an increased response to procoagulants in patients with diabetes. Platelet hyperactivity, in the presence of oxidative stress, has a major effect on the progression of thrombotic and CVD events. This review will discuss the impact of the above factors and the potential effects of platelet hyperactivity on thrombotic and cardiovascular risks.

摘要

在许多国家,最常见的慢性疾病之一是 2 型糖尿病(T2DM)。T2DM 是心血管疾病(CVD)的独立危险因素。心脏病是糖尿病患者死亡的原因之一,主要是由于大血管并发症。糖尿病的大血管并发症之一是动脉粥样硬化,它涉及一个复杂的病理生理过程。除了高血糖,氧化应激在糖尿病的发病机制及其相关的 CVD 风险中起着重要作用。还有许多其他因素,包括分子、代谢、脂质、纤溶和血小板功能障碍,导致 T2DM 中的血栓形成和 CVD 风险增加。此外,糖尿病患者的血小板对促凝剂的反应增加。在氧化应激的情况下,血小板的高活性对血栓形成和 CVD 事件的进展有重大影响。这篇综述将讨论上述因素的影响以及血小板高活性对血栓形成和心血管风险的潜在影响。

相似文献

1
Thrombotic and cardiovascular risks in type two diabetes; Role of platelet hyperactivity.二型糖尿病的血栓形成和心血管风险;血小板活性亢进的作用。
Biomed Pharmacother. 2017 Oct;94:679-686. doi: 10.1016/j.biopha.2017.07.121. Epub 2017 Aug 16.
2
Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies.2 型糖尿病中的血管内皮功能障碍和血小板高反应性:分子见解和治疗策略。
Cardiovasc Diabetol. 2018 Aug 31;17(1):121. doi: 10.1186/s12933-018-0763-3.
3
Potential of Anthocyanin to Prevent Cardiovascular Disease in Diabetes.花青素预防糖尿病心血管疾病的潜力。
Altern Ther Health Med. 2018 May;24(3):40-47.
4
Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.2 型糖尿病患者的高血糖和心血管危险因素的早期强化治疗。
Clin Ther. 2011 Jun;33(6):665-78. doi: 10.1016/j.clinthera.2011.04.025.
5
[Diabetes, coagulation and vascular events].[糖尿病、凝血与血管事件]
Recenti Prog Med. 2000 Feb;91(2):86-90.
6
Molecular mechanism for accelerated atherosclerosis in diabetes and its potential therapeutic intervention.糖尿病中动脉粥样硬化加速的分子机制及其潜在的治疗干预措施。
Int J Clin Pharmacol Res. 2004;24(4):129-34.
7
Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus.影响糖尿病患者对阿司匹林反应的氧化应激相关机制。
Free Radic Biol Med. 2015 Mar;80:101-10. doi: 10.1016/j.freeradbiomed.2014.12.010. Epub 2014 Dec 18.
8
Platelet Oxidative Stress and its Relationship with Cardiovascular Diseases in Type 2 Diabetes Mellitus Patients.血小板氧化应激与 2 型糖尿病患者心血管疾病的关系。
Curr Med Chem. 2019;26(22):4145-4165. doi: 10.2174/0929867324666171005114456.
9
Interplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitus.2型糖尿病中超微结构发现与动脉粥样硬化血栓形成并发症之间的相互作用。
Cardiovasc Diabetol. 2015 Jul 31;14:96. doi: 10.1186/s12933-015-0261-9.
10
[The role of postprandial hyperglycemia in the development of cardiovascular diseases in type 2 diabetes mellitus].[餐后高血糖在2型糖尿病心血管疾病发生中的作用]
Klin Med (Mosk). 2009;87(11):17-24.

引用本文的文献

1
Case Report: Diagnosis, treatment and follow-up of venous thrombosis in adolescent diabetic patients with SARS-CoV-2.病例报告:感染SARS-CoV-2的青少年糖尿病患者静脉血栓形成的诊断、治疗及随访
Front Pediatr. 2025 Aug 11;13:1562590. doi: 10.3389/fped.2025.1562590. eCollection 2025.
2
Acute Hyperglycemia-Induced Injury in Myocardial Infarction.急性高血糖诱导的心肌梗死损伤。
Int J Mol Sci. 2024 Aug 4;25(15):8504. doi: 10.3390/ijms25158504.
3
Ticagrelor monotherapy after a short course of dual antiplatelet therapy with ticagrelor plus aspirin following percutaneous coronary intervention in patients with versus without diabetes mellitus: a meta-analysis of randomized trials.
替格瑞洛单药治疗与替格瑞洛加阿司匹林双联抗血小板治疗在经皮冠状动脉介入治疗后的短期疗程后在伴有或不伴有糖尿病的患者中的应用:随机试验的荟萃分析。
BMC Cardiovasc Disord. 2024 Mar 19;24(1):166. doi: 10.1186/s12872-024-03836-9.
4
Predictive value of bilirubin and serum γ-glutamyltranspeptidase levels in type-2 diabetes mellitus patients with acute coronary syndrome.胆红素和血清γ-谷氨酰转肽酶水平对2型糖尿病合并急性冠状动脉综合征患者的预测价值
World J Diabetes. 2024 Jan 15;15(1):34-42. doi: 10.4239/wjd.v15.i1.34.
5
Molecular Mechanisms Linking Diabetes with Increased Risk of Thrombosis.糖尿病与血栓形成风险增加相关的分子机制。
Int J Mol Sci. 2023 Dec 14;24(24):17465. doi: 10.3390/ijms242417465.
6
Novel wine in an old bottle: Preventive and therapeutic potentials of andrographolide in atherosclerotic cardiovascular diseases.旧瓶装新酒:穿心莲内酯在动脉粥样硬化性心血管疾病中的预防和治疗潜力
J Pharm Anal. 2023 Jun;13(6):563-589. doi: 10.1016/j.jpha.2023.05.010. Epub 2023 May 20.
7
Type 2 Diabetes Mellitus, Platelet Activation and Alzheimer's Disease: A Possible Connection.2型糖尿病、血小板活化与阿尔茨海默病:一种可能的联系。
Clin Neuropsychiatry. 2022 Dec;19(6):370-378. doi: 10.36131/cnfioritieditore20220604.
8
Relationship between the Soluble F11 Receptor and Annexin A5 in African Americans Patients with Type-2 Diabetes Mellitus.非裔美国2型糖尿病患者中可溶性F11受体与膜联蛋白A5的关系
Biomedicines. 2022 Jul 28;10(8):1818. doi: 10.3390/biomedicines10081818.
9
Endothelial Dysfunction and Platelet Hyperactivation in Diabetic Complications Induced by Glycemic Variability.血糖波动导致糖尿病并发症中的内皮功能障碍和血小板过度激活。
Horm Metab Res. 2022 Jul;54(7):419-428. doi: 10.1055/a-1880-0978. Epub 2022 Jul 14.
10
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? .接受经皮冠状动脉介入治疗的患者的血糖控制:新型抗糖尿病药物的作用是什么?
Int J Mol Sci. 2022 Jun 30;23(13):7261. doi: 10.3390/ijms23137261.